Barnéoud P, Neveu P J, Vitiello S, Le Moal M
INSERM U.259, Université de Bordeaux II, Domaine de Carreire, France.
Immunol Lett. 1990 Mar-Apr;24(1):31-5. doi: 10.1016/0165-2478(90)90032-l.
The cerebral neocortex is known to modulate the immune system in an asymmetrical way. Ablations of the left cortex decrease, whereas symmetrical right lesions have no effect, or enhance, T cell functions measured 6-8 weeks after lesioning. However, modifications of immune responses induced by lesions of the brain neocortex could result from a lymphocyte redistribution mediated by glucocorticoids, like that observed during stress. We tested this possibility in the present experiments. Cortical lesions modulated concanavalin A-induced proliferation of both lymph node and spleen lymphocytes in a similar way. Cortical lesions of either side modified neither the lymphocyte distribution of 51Cr-labelled injected lymph node cells, nor the percentage of blood cell subsets. These results show that cortical lesions do not affect lymphocyte homing, and suggest that the brain neocortex immunomodulatory effects are not mediated by glucocorticoids.